Revolution Medicines, Inc. (RVMD)

209.18 -0.69 (-0.33%) USD  |  NASDAQ  |  Sep 02, 16:00
209.32 +0.14 (+0.07%) After-Hours: 16:53
More

Revolution Medicines Total Long Term Debt (Annual)

Total Long Term Debt (Annual) Chart

View Total Long Term Debt (Annual) for RVMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Annual) Chart
Start Trial

Historical Total Long Term Debt (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
December 31, 2022 --
December 31, 2021 --
Date Value
December 31, 2020 --
December 31, 2019 --
December 31, 2018 --
December 31, 2017 --

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Annual) Range, Past 5 Years

View Total Long Term Debt (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Annual) Benchmarks

View Total Long Term Debt (Annual) Benchmarks
Start Trial
Tango Therapeutics, Inc. Upgrade
Erasca, Inc. Upgrade
Moderna, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade